Novartis Recalls Triaminic Vapor Patch




PARSIPPANY, N.J. - Novartis Consumer Health said it is conducting a voluntary nationwide recall of its Triaminic Vapor Patch products due to several reports of serious adverse health effects, including seizures.

Novartis said it is recalling the products because serious adverse health effects could result if the Vapor Patch is ingested by a child removing the patch and chewing on it. Novartis warned that consumers who have Triaminic Vapor Patches should stop using them immediately because the company has received multiple complaints of injuries, including seizures.

Reported adverse events associated with swallowing products containing camphor or eucalyptus oils, such …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS